Peer Review History
| Original SubmissionJune 4, 2020 |
|---|
|
PONE-D-20-16928 Nurse-sensitive outcomes in district nursing care: a Delphi study PLOS ONE Dear Dr. Veldhuizen, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. In particular, this paper would benefit from additional rigour in reporting and this should include justification for the methodological choices made within the Delphi rounds. The reviewers also comment that this paper needs international appeal, so a clearer explanation of the role of the District Nurse in other countries or contexts would be helpful. Please submit your revised manuscript by Jan 14 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Fiona Cuthill, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2.We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Your paper is interesting and i enjoyed reading it. Thank you! I did not see the supporting information and perhaps some of my comments are covered in that. I offer you some comments and signposts to strengthen the paper. I hope you find them helpful. For international appeal, identify different similar roles. The definition given does not resinate with the UK DN role, so articulate which country this reflects. I don’t know the study is conducted in the Netherlands until p6, so perhaps this needs to be in the aim In questionnaire development section, i’d like to understand how these indicators are worded. i know it will be in supplementary information, but perhaps including a box with some examples might help. I understand what you mean by nurse-sensitive outcomes, but i want to be convinced that the outcomes of the indicators are for patients/families living at home. On pg 13 in the Delphi Round table 2, the list on the left hand side (with no title) - are these the indicators? If so, how do e.g. falls or instrumental activities of daily living measure patient experience, health and well-being etc that you said you wanted to measure? on p17, i can see that the outcomes in the first column would be outcomes to strive for, but in the middle and the last column, would an outcome really be dehydration? I don’t understand the terminology, instrumental activities of daily living. p7L119 - what original reference are you referring to? p7 L120 - If no definition was provided, other references were used - I’m not sure what this means. can you please clarify. p7 121 - how did the authors decide the themes? Link back to what you think is missing in the outcomes literature P8 L130 - 138 - i don’t think this fits here as experts are referred to but they haven’t been defined. P8 L 131- who was the letter given to and how were they sampled? Why are they considered experts? these questions cos you haven’t identified experts yet. P8 - were experts from a diversity of services/communities/organisations? Please identify. Demographics of the expert panel on pg 11/12 would be better moved to p8 as it answers these questions. You have achieved a good balance of participants. p9 L165 - how many outcomes were added after round one and how did the team make the decision to include them? p12 L 214 - remind the reader how many outcomes were considered. p15 - I can’t see C Newly added outcomes after Delphi round one in the table p17 - Table header hat needs separated Discussion - in the background section you have offered some critique on Joling’s and ICHOM use of outcomes and suggest that they are not dN sensitive and that they do not emphasise outcomes for patients’s health status/well-being. Rather than comparing your findings with these papers, emphasis where your findings do exactly that. So difference, rather than similarity. More literature could be used to unpack findings in this section. I think this would strengthen your discussion. What would also strengthen your discussion is how these findings could be useful in the global context to improve the quality of DN and community services. You have put this in the conclusion but it might be better here. Limitations - there may be some limitations in the way the outcomes are written and how they were themed (this isn’t clear) I’d place the acknowledgement that these outcomes are for older people only and therefore some limitation in application to enhance DN service. Conclusion - its great to hear these have the potential to be included in policy development. Well done! Reviewer #2: Hello Thank you for the opportunity to review your manuscript. I have a few general comments and then some more specific additional comments. Delphi studies generally require some justification as to how they choose the "expert panel". You have provided some appropriate discussion on this. I am interested to know however whether your panel were appropriate to answer your research questions. Less than half of participants in Round 1 were District Nurses (46.7% as per Table 1). Given the small numbers of participants in your Delphi rounds I think this requires additional discussion in your methods. How did you decide on numbers and sample size? What is your justification for the approach you have used? The rigour of your project relies on asking the questions to the "right" people"? Years of experience in district nursing and current area of waork does not make individuals experts. Some additional context is required to suppiort your choices. You have used Medians to analyse all data. Do you have a justification for this? Why use Medians rather than Means? I would recommend a methodological reference to support this approach. Providing the definitions in the Supplementary material was helful. Thankyou. Presenting the example of Mobility provided clarity about how this was presented. I am not sure however, how "sensitive" mobility is to district nursing care. Our physiotherapist and occupational therapist colleagues would question whether mobility is truly sensitive to nursing care. When we rate the relevance of mobility as a nursing sensitive outcome for district care - what are we rating? Mobility is most frequently considered a characteristic of the person receiving care (and all patients are different with different mobility impairments). Is making someone more mobile a nursing outcome? It might be but I think we are oversimplifying this. I think improving mobility is an appropriate outcome for the healthcare team. What makes it nursing-sensitive? I can see that an additional 5 outcomes were added after Round 1. What was the process used to define these additional outcomes? They are included as definitions in supplemental material 1 but I am unsure of the source of this definition. See "Quality of death and dying". The definition here is "Discuss timely the options and take care of counselling in the palliative and terminal phase". This is not a very objective definition and may not actually be about "quality" of death and dying from a patient's perspective. Clarity is needed here. I also have the following additional comments: - Line 49. There is a 1 at the end of this first sentence? Is this meant to be a reference? - Line 125. Nurse-sensitiveness is not an actual word. i would suggest you use 'sensitivity to nursing care' throughout your paper - The CREDES checklist needs to be updated to reflect the page numbers for the required content (rather than the manuscript section) There are a number of other manuscripts published that have used Delphi methods to develop a list of potential nursing-sensitive indicators. It may be useful to look at these to guide the reporting of your work. Kind regards The Reviewer ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Caroline Dickson Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Nurse-sensitive outcomes in district nursing care: a Delphi study PONE-D-20-16928R1 Dear Dr. Veldhuizen, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Fiona Cuthill, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Thank you very much for addressing my comments and re-submitting your manuscript. I wish you well with your work and hope the paper achieves some impact. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Dr Caroline Dickson |
| Formally Accepted |
|
PONE-D-20-16928R1 Nurse-sensitive outcomes in district nursing care: a Delphi study Dear Dr. Veldhuizen: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Fiona Cuthill Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .